Hedgehog inhibitor sonidegib potentiates 177Lu-octreotate therapy of GOT1 human small intestine neuroendocrine tumors in nude miceJohan Spetz, Eva Forssell‐Aronsson|BMC Cancer|2017Cited by 31
A window-of-opportunity trial reveals mechanisms of response and resistance to navtemadlin in patients with recurrent glioblastomaVerónica Rendo, Rameen Beroukhim, Eudocia Q. Lee et al.|Science Translational Medicine|2025Cited by 13
Abstract 6130: Cancer sensitivity to therapy is constrained by apoptosis regulation in cells of originFraser Cameron, Kristopher A. Sarosiek, Stacey Yu et al.|Cancer Research|2023Cited by 1